4.3.3 Diagnostics Moves Out of the Hospital
4.3.4 Disruption Looms
5. PCR Recent Developments
5.1.1 Importance of These Developments
Scope Fluidics Secures €6.2M Supporting Rapid MDx
Quidel Expects SARS-CoV-2 Testing Demand to Continue Through 2022, and Beyond
Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
Israel s Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study
Global Human Gene Sequencing Market Report 2021-2025: COVID-19 Pandemic has Put the Market on Pause prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
4.2.3 Wellness Hurts
4.3 Diagnostic Technology Development1
4.3.2 NAT vs. Lateral Flow
4.3.3 The Unusual Role of GPS
4.3.4 Self and Send Competition
4.4.5 The Relationship to DTC Genetic
4.4.6 The Relationship to TeleHealth
4.4.7 Sample Collection - Who Knew?
5. OTC/DTC Infectious Disease Testing Recent Developments
Recent Developments - Importance and How to Use This Section
Importance of These Developments
FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
Lucira Health Files for $115M IPO
Spectrum Solutions Gets CE Mark for Saliva Collection Devices
Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test
LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit
3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.2 Single Cell Genomics Changes the Picture
3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.4 CGES Testing, A Brave New World
3.4.5 Biochips/Giant magnetoresistance based assay
4. Cancer Panels & Profiles Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Metastatic Cancer Markers Identified in Clinical WGS Study
Stitch Bio Bets on CRISPR Tech
Bayer, LifeLabs Launch Free NTRK Genetic Testing Program
Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Dx
A market with fundamental growth factors is impacted by the COVID-19 Pandemic.
Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.
Working against this dynamic market are the forces of the COVID Driven Recession. The publisher s latest numbers factor in the different COVID forces, their timing, and their effect on growth.